Post job

Vaxart's revenue is $28.7 million.

What is Vaxart's revenue?

Vaxart's annual revenue is $28.7M. Zippia's data science team found the following key financial metrics about Vaxart after extensive research and analysis.
  • Vaxart's revenue growth from 2017 to 2024 is 222.47%.
  • Vaxart has 110 employees, and the revenue per employee ratio is $260,909.
  • Vaxart's peak quarterly revenue was $15.2M in 2024(q4).
  • Vaxart peak revenue was $28.7M in 2024.
  • Vaxart annual revenue for 2023 was 7.4M, 6,796.26% growth from 2022.
  • Vaxart annual revenue for 2024 was 28.7M, 288.94% growth from 2023.

On this page

Most recent quarter revenue
$15.2M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$28.7M (2024)
Company peak revenue
Revenue / employee
$260,909
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Most recent quarter revenue
$15.2M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$28.7M (2024)
Company peak revenue
Revenue / employee
$260,909
Company revenue / employee

Vaxart historical revenue

Vaxart's peak revenue was $28.7M in 2024. The peak quarterly revenue was $15.2M in 2024(q4).

Vaxart's revenue increased from $8.9m in 2017 to $28.7M currently. That's a 222.47% change in annual revenue.

Vaxart annual revenue

$29M
$23M
$17M
$11M
$6M
$0
2019
2020
2021
2022
2023
2024

Vaxart annual revenue over time

Fiscal year / yearVaxart revenue
2017$8.9M
2018$4.2M
2019$9.9M
2020$4.0M
2021$892,000
2022$107,000
2023$7.4M
2024$28.7M

How accurately did Vaxart's revenue projections match actual performance?

Zippia waving zebra

Vaxart annual growth

Vaxart saw the greatest revenue growth in 2019, when revenue increased by 137.12%.

Vaxart had the lowest revenue growth in 2022, when revenue changed by -88.0%.

Vaxart annual growth rate over time

YearVaxart growth
2018
-53%
2019
137%
2020
-59%
2021
-78%
2022
-88%
2023
6796%
2024
289%

Vaxart quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$15M
$12M
$9M
$6M
$3M
$0
2020
2021
2022
2023
2024

Vaxart quarterly growth rate over time

YearQ1Q2Q3Q4
2017$100,212$3.8M$4.9M$99,796
2018$100,064$2.7M$1.5M$608,995
2019$280,849$1.8M$5.4M$84,912
2020$2.9M$523,000$265,000$356,000
2021$506,000$112,000$200,000$74,000
2022$85,000--$22,000
2023$277,734$29,954$445,570$6.6M
2024$2.2M$6.4M$4.9M$15.2M

Vaxart jobs nearby

Do you work at Vaxart?

Is Vaxart transparent about its revenue structure?

Vaxart financial information

CEOAndrei Floroiu M.b.a
IndustryPharmaceuticals, Biotechnology & Life Sciences
Company TypePublic
Employees Number110
Date Founded2004
HeadquartersSouth San Francisco, California
Number of Locations1
Revenue$28.7M
Net Income-$107,758,000
PE Ratio-0.19
Tax Rate-0.0%
Market Capitalization$12.6M
Total Assets$153,847,000
TickerVXRT

Vaxart jobs you might like

Vaxart financing

Vaxart received early financing of $3.3M on 2007-11-15.

SeriesRound sizeDate
Series A$3.3M11/2007
Series B$3.5M01/2010
Series B$9M03/2010
Series B$16.9M06/2012
Series C$20M08/2013

Vaxart investors

InvestorsSecurity type
Bay PartnersSeries A
Life Science Angels IncSeries A
Sand Hill AngelsSeries A
Quantum Technology PartnersSeries A
Life Science Angels IncSeries B
Quantum Technology PartnersSeries B
Care CapitalSeries B

Vaxart competitors

Vaxart's top competitor, Merck, earned an annual revenue of $64.2B.

Vaxart's smallest competitor is CytoLogic with revenue of $250.0K last year.

Vaxart revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Vaxart, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Vaxart. The employee data is based on information from people who have self-reported their past or current employments at Vaxart. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Vaxart. The data presented on this page does not represent the view of Vaxart and its employees or that of Zippia.

Vaxart may also be known as or be related to VAXART, INC., Vaxart, Vaxart Inc and Vaxart, Inc.